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lipid raftVoltage-gated sodium channels are abnormally expressed in tumors, often as neonatal isoforms, while they are
not expressed, or only at a low level, in thematching normal tissue. The level of their expression and their activity
is related to the aggressiveness of the disease and to the formation of metastases. A vast knowledge on the
regulation of their expression and functioninghas been accumulated innormal excitable cells. This helpedunder-
stand their regulation in cancer cells. However, how voltage-gated sodium channels impose a pro-metastatic
behavior to cancer cells is much less documented. This aspect will be addressed in the review. This article is
part of a Special Issue entitled: Membrane channels and transporters in cancers.
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).1. Introduction
Voltage-gated sodium channel alpha subunits (VGSC, term that will
be used throughout this article when not referring to a particular iso-
form) were discovered more than 60 years ago. They have been exten-
sively characterized for the electrogenic role they play in neurons
(NaV1.1, 1.2, 1.3, 1.6, 1.7, 1.8, and 1.9, respectively coded by genes
SCN1A, SCN2A, SCN3A, SCN8A, SCN9A, SCN10A, SCN11A), skeletal muscle
cells (NaV1.4, gene SCN4A) and cardiac muscle cells (NaV1.5, gene
SCN5A). This role in the generation of the action potential and its prop-
agation is now well described [1,2].
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documented the expression of one or more types of these channels in
non-excitable cells, where they regulate physiological functions such
as phagocytosis, endocytosis, secretion, or motility [3], referred to as
noncanonical roles for VGSC as reviewed recently by J.A. Black and S.G.
Waxman, and more generally, cell proliferation [4], differentiation
[5], as well as the organization of the cells during embryo development
[4,6].
Many other studies during the same last two decades have described
the anomalous expression of VGSC in cancer cells, where they were as-
sociated with increased cell motility or invasiveness, therefore increas-
ing the risk of metastases development. Generally, comparative studies
showed that they are not expressed, or only at a low level in the corre-
sponding non-cancer cells [7].
Many studies have investigated how partner proteins regulate VGSC
activity (for examples, see reviews [8–10]). However, howVGSC activity
can increase the motility or invasiveness of cancer cells, therefore in-
creasing the risk of metastases development, remains largely unknown.
Some of the proteins that interact, directly or indirectly, with the chan-
nels andmodulate their activity, alsomight be the vector throughwhich
VGSC exert their pro-invasive effect.
In this article, we will review the roles of VGSC in the motile and
invasive properties of cancer cells, and the mechanisms or partner
proteins proposed for these functions. We will also try to show which
aspects are lacking for the understanding of their implication in the
formation of metastases.2. VGSC in cancer cells and normal corresponding tissues
VGSC have been discovered in a wide variety of metastatic cancers
(see Table 1). They were reported in carcinoma cell lines derived from
small-cell lung cancer [11], prostate cancer [12], melanoma [13], breast
cancer [14], neuroblastoma [15],mesothelioma [16], non-small cell lung
cancer [17], cervical cancer [18], ovarian cancer [19], and colon cancer
[20]. VGSC are also present in other cancer types (gliomas [21,22] or
lymphoma [23] or leukemia cells [23]). In some cancers, this is an
abnormal expression of functional channels in cancer cells while their
normal cognate cells are not known to have VGSC currents. This is sug-
gested by two kinds of data: 1) electrophysiological investigations in
corresponding normal cells could not detect inward sodium currents
although the proteinwas present [17] or 2) the comparison of immuno-
histochemical stainings in tumor and non-tumor corresponding tissues
have shown that VGSC were expressed in tumors, not in the normal
epithelial biopsies [7,24]. In contrast, in the case of colon cancer, ovarian
cancer, cervical cancer, glioma and leukemia, the expression of VGSC is
not abnormal, but rather, the level of overexpression of VGSC in these
tissues seems to be related to tumor aggressiveness. Indeed, the cognate
stem cells, progenitor cells, or related normal cells (normal colon [20],
normal ovary [25,26], normal cervix cells [27], glial cells [3] or leuko-
cytes [28,29]) also express VGSC.
It is important to note that in some instances, the expressed
isoform is a fully functional neonatal splice variant [24], which is ac-
tive during embryonic life but is no longer expressed in the young
and the adult. This is interesting regarding the possibilities to develop
drugs that could be used to speciﬁcally inhibit the neonatal VGSC,
leaving the adult isoform fully functional in the excitable cells. There-
fore, there is a double abnormality: 1) the expression of a gene nor-
mally silenced in a tissue where it is not supposed to be expressed
and 2) a neonatal isoform is produced by alternative splicing.
This feature is often found in cancer cells where silenced genes be-
come expressed again, resulting in dedifferentiation [30,31]. In the
case of those VGSC that are expressed as neonatal isoform, not only
the gene is transcribed in the wrong cells, but along with it, the
genes of proteins that regulate developmental differential splicing
[32].3. Proteins that modulate the activity of voltage-gated sodium
channels by direct or indirect interaction
A vast amount of knowledge is available concerning the proteins
that directly or indirectly interact with, and modulate the expression
and/or activity of VGSC (for reviews see [8–10]). Most of this knowledge
was obtained in excitable cardiac and neuronal cells and was used as
a guide for the investigations in cancer cells. Here are a few examples
of the proteins with direct or indirect actions on VGSC, discovered in
studies performed on excitable cells (Fig. 1).
VGSC, which consist of a main α subunit forming the channel, is
associated with one or two β subunits among the four isoforms
β1, β2, β3, and β4 (respectively encoded by genes SCN1B, SCN2B,
SCN3B and SCN4B). These β subunits modulate the activation–inactiva-
tion properties of the channel, thus modulating the sodium current (for
a review see [2]). They also exert other properties, not directly related to
the regulation of the sodium ﬂux, such as VGSC addressing to speciﬁc
domains of the membrane; adhesion properties through interaction of
their extracellular extremity with the extracellular matrix or via trans
homophilic adhesion [33,34]; anchoring to the cytoskeleton through
interaction with their intracellular C-terminal; and scaffolding for vari-
ous other proteins (for a review see [35]). Another way β subunits
could regulate sodium current density is by modulating the transcrip-
tion of VGSC genes. It was reported that the intracytoplasmic domain
of β2, after cleavage by protease BACE1, increased the transcription
of SCN1A and increased the expression of NaV1.1 in mouse brain, but
reduced its addressing to the membrane [36]. Subunit β4 was also
reported to be a substrate of proteases BACE1 and γ-secretase in the
brain of mice, and β1, β2 and β3 were substrates as well in transfected
cell models [37].
VGSC have been shown to interact withmany scaffolding (or adapt-
er) proteins such as syntrophins and dystrophin [38], caveolin-3 in stri-
ated muscle [39], and ankyrin-G [40,41]. These scaffolding proteins
recruit various other proteins to make multiprotein complexes in mul-
tifunctional lipid microdomains. The proteins recruited in the domains
interact directly or indirectly with VGSC. Here are a few examples of
the multiple partners that modulate VGSC expression, localization and
activity.
Calmodulin and FHF (ﬁbroblast growth factor homologous factor)
associate with NaV1.5 C-terminal domain to form a ternary complex
[42]. FHF also binds a scaffold protein (IB2) that recruits MAP kinases
[43]. All these gathered proteins participate in the modulation of VGSC
localization and activity by phosphorylation.
Ubiquitin ligases nedd4 and nedd4-2 bind VGSC, attach one, two, or
more ubiquitin units and regulate the channel density at themembrane
through internalization followed by degradation [44–47].
PKA and PKC can be recruited by another family of anchoring protein:
AKAP (A kinase anchoring protein). It was shown in rat brain that
NaV1.2 binds AKAP15, which recruits PKA and PKC. PKA activity on
NaV1.2 reduces the sodium current and PKC activity further enhances
this reduction. The platform constituted by the recruitment of PKA and
PKC by AKAP near NaV1.2 allows the integration of several signaling
pathways [48]. No other study reports such an association with other
VGSC but the contrasting effects of phosphorylation by PKA and PKC
on VGSC that are reported in differentmodels (animal species, VGSC iso-
forms) could be in part due to the various members of AKAP expressed.
PKA is not always associated with AKAP but is also found associated
with caveolin in caveolae (caveolin-containing lipid rafts) [49]. Since
VGSC are also present in caveolae [50], the association between
PKA and caveolin facilitates the regulation of VGSC presence/activity
in the lipid rafts.
Fyn (a member of the src family kinases) which is present in lipid
rafts [51] also interacts and phosphorylates VGSC [52,53].
Also present in lipid rafts [54], Sigma-1 receptor binds VGSC with a
4-fold symmetry (1 sigma-1 receptor per set of six transmembrane
regions) [55] and regulate its activity [55,56]
Table 1
Occurrence of gene transcripts, protein, sodium currents, and role of VGSC in cancer cells and the corresponding non-cancer cells.
First reported on year: Cancer tissue — mRNA, protein Cancer tissue — Na+ current, function Corresponding non-cancer tissue — mRNA, protein Corresponding non-cancer tissue — Na+
current, function
1989 Small-cell lung cancer VGSC current (type not identiﬁed) in small-cell
lung cancer cells [11]
Expression of protein (immunolabeling) in normal
lung biopsies [92].Expression (mRNA detection by
RT-PCR) of NaV1.1 to NaV1.3 and NaV1.5 to NaV1.8
with different proﬁles in two immortalized normal
lung epithelial cell lines; NaV1.7 protein detected in
intracellular membranes, not at plasma membrane
[17]. NaV1.7 protein immuno-detected faintly in
epithelium of normal lung biopsies [7]
No VGSC currents detected [17].
2007 Non-small cell lung
cancer
Expression (mRNA detection by RT-PCR) of NaV1.1 to
NaV1.9 with different proﬁles [17]
VGSC currents in different non-small cell lung
cancer cell lines; VGSC current involved in
increased invasive capacity [17]
1995 Prostate cancer VGSC current (type not identiﬁed) in rat prostate
cancer cells [12]; VGSC current involved in
secretory activity [72]; major isoform identiﬁed as
NaV1.7 [93]
Expression of mRNA (assessed by RT-qPCR) of all NaV1
isoforms except for NaV1.4 and NaV1.8 in normal
prostate tissue and benign prostate hyperplasia [94].
Expression of VGSC protein (type not identiﬁed,
immunolabeling) in normal prostate biopsies [95]
1997 Melanoma VGSC current (type not identiﬁed) in melanoma
cells [13]
VGSC current (type not identiﬁed) in normal
human melanocytes [96]
2002 Glioma Expression (mRNA detection by RT-PCR) of NaV1.1,
NaV1.2, NaV1.3, NaV1.4, and NaV1.6 in gliomas [21]
Expression (immunolabeling of protein) of NaV1.1,
NaV1.5, and NaV1.6 [3]
NaV1.1 and NaV1.6 play role in cytokines release
in glial cells [3]
2003 Breast cancer NaV1.5 current in human highly invasive breast
cancer cell line, role in invasive properties, no
current or role in invasiveness in less invasive
cancer cell lines [14]
No or very low expression (immunolabeling of
protein) in biopsies of breast tissue [24]
No current in non-cancer human breast cell line
[24]
2004 Lymphoma Expression (mRNA detection by RT-PCR) of NaV1.5,
NaV1.6, NaV1.7, and NaV1.9 in lymphoma cell line [23]
NaV1.5 plays a role in invasiveness [23] VGSC current (type not identiﬁed) in normal
human lymphocytes (3 cells out of 90)[97]
Phagocytosis by macrophages regulated by
NaV1.5; protein localized in late endosome [28]
2006 Mesothelioma Expression (mRNA detection by RT-PCR) of NaV1.2,
NaV1.6, and NaV1.7, and less for NaV1.3, NaV1.4, and
NaV1.5 in mesothelioma cells along with the
disappearance of the 3 potassium currents found in
normal mesothelial cells [16]
Sodium current recorded in mesothelioma cells and
involved in cell migration [16]
Normal mesothelial cells do not have any VGSC
current while they express 3 main potassium
currents [16]
2007 Cervix cancer Expression (mRNA detection by RT-PCR) of NaV1.1,
NaV1.4, NaV1.6, and NaV1.7 in cervical cancer cells [18]
Measurement of tetrodotoxin-sensitive VGSC
currents in cervical cancer cells [18]
Expression (mRNA detection by RT-PCR) of NaV1.4 in
normal cervix cells; [18]; proteins NaV1.6 and NaV1.7
were immuno-detected in normal cervix cells [27]
Current was not detectable in normal cervix
cells [18,27]
2010 Colon cancer Expression of NaV1.5 protein (immuno-detection) in
colon cancer biopsies [20]
NaV1.5 current measured in colon cancer cell lines
NaV1.5 expression involved in cancer cell
invasiveness [20]
NaV1.5 protein immuno-detected faintly in biopsies of
normal colon [20]
2010 Ovarian cancer Expression (mRNA detection by RT-PCR) of NaV1.1 to
1.9 in ovarian cancer cells; NaV1.5 immuno-detected in
ovarian cancer cell lines and tumor biopsies [19]
Tetrodotoxin-resistant VGSC involved in cell
invasive capacity [19]
VGSC protein (type not identiﬁed) expressed (western
blot, immuno-staining of biopsies with pan NaV
antibody) in normal corpus luteum cells of the ovary;
VGSC identiﬁed as NaV member by RT-PCR [25,26].
Expression (mRNA detection by RT-PCR) of NaV1.1 to
1.9 in biopsies of normal ovary and benign ovarian
tumors; NaV1.5 immuno-detected in biopsies of
normal ovary and benign ovarian tumors [19]
VGSC current recorded, inhibited by
tetrodotoxin; involved in physiological
luteolysis of normal corpus luteum cells of the
ovary [25,26]
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Fig. 1. Schematic interactions of scaffolding and regulatory proteinswith VGSC at the plasmamembrane and in endosomes. VGSC alpha-subunits (αNaV) interactwith scaffolding proteins
such as IB2 [43], AKAP [48], syntrophin (Syn) [38], ankyrin (Ank) [40,41], GPI-anchored contactin (Cont) [51,69], caveolin 3 (Cav) [39] and other proteins (sigma1 receptor: Sig [54–56];
VGSC beta subunits: β-subunit [2,33–35]) to make large multiprotein complexes. Kinases such as PKA [48,49,71], PKC [48], MAPK [43], and CamKII [68] are recruited in these complexes
andmodulate the activity ofαNaV and also channel density at themembrane. The sodium-calcium exchanger (NCX) functioning in reversemodewas shown to be a part of this regulation
through CamKII [68]. Proteases BACE1 and γ-secretase can cleave β-subunits [37]. The C-terminus of β1 subunit was shown to be a transcription factor for αNaV [36]. Ubiquitin ligase
Nedd4 interacts with αNaV and transfers several ubiquitins (Ub), leading to the degradation of αNaV [44–47]. VGSC activity stimulates the invasiveness of cancer cells. It was shown
that sodium entry through VGSC leads to the formation and activity of invadopodia [50,74–77], with the polymerization of actin and increase in sodium-proton exchanger type 1
(NHE1) activity [50,74], acidiﬁcation of the extracellular surface of the plasma membrane making a favorable milieu for the activity of acidic cysteine cathepsins [73]. Similarly, the
presence ofαNaV in late endosomes ofmacrophageswas shown to regulate endosomal acidiﬁcation and phagocytosis [28]. How sodium ions are involved in theVGSC-dependentmotility
and invasiveness of cancer cells is not known (box with "?"). Candidate kinases are Fyn or members of the Src family kinases [51–53,69,74]. GPI: glycosylphosphatidylinositol.
2496 P. Besson et al. / Biochimica et Biophysica Acta 1848 (2015) 2493–2501Two VGSC α subunits can also interact with one another, as was
recently shown; this interaction modulates the trafﬁcking and activity
of NaV1.5; the direct interaction is located at their N-terminal region
[57,58].
The sodium-calcium exchanger NCXwas also found to be associated
with annexin-3 in lipid rafts of cardiac cells [59,60] and associated with
various VGSC isoforms in intraepidermal nerve terminals [61].
Depending on the VGSC isoform and the excitable cells, many differ-
ent proteins have been found to interact with VGSC (for more details,
see reviews [8–10]).
It is therefore understandable that the large protein complexes
comprising VGSC, in bringing multiple partners in close proximity to
their multiple targets, permit the modulation of the channel activity.
It is important to stress that the association of partner proteins in
membrane lipid rafts is dynamic and can be altered by post-translation
modiﬁcations such as palmitoylation [62] or association with special
phospholipids such as phosphatidylinositol-bis-phosphate PIP2 [63].
It is also dependent on the lipid composition of rafts as was shown
in breast cancer cell line MDA-MB-435S: a protein complex comprising
Orai1 and SK3 channels, whichwas functional within caveolin-rich lipid
rafts, dissociated and became inactive upon the introduction of a syn-
thetic analogue of ether-phosphatidylcholine [64]. It is then conceivable
thatmodiﬁcations of dietary lipids or pharmacological interventionwith
synthetic lipid analogues might disrupt the pro-invasive property ofVGSC. Reports on breast cancer cell line MDA-MB-231 indicate that
NaV1.5 is sensitive to n-3 long chain polyunsaturated docosahexaenoic
acid (DHA, 22:6n-3), which was supplemented in the culture medium.
The sodium current and migration MDA-MB-231 cells, along with
NaV1.5 mRNA and protein levels were reduced by DHA [65], as were
invasiveness and the relation (explained below in Section 4) between
the activities of NaV1.5 and NHE-1 [66].4. Proteins that are, directly or indirectly, modulated by
VGSC activity
In these large multiprotein complexes, the activity of the channel
could in turn inﬂuence the behavior of one or several of the proteins
in the scaffold (whether it is through Na+ ions or through themodula-
tion of membrane potential, or both, is not clear yet). This could be how
a signal triggered by VGSC activity is transduced or propagated to
produce its effects on motility or invasiveness of cancer cells.
For example (although the mechanism of regulation is not known),
the activity of the channel was shown to regulate the splicing of VGSC
mRNA: in a drosophila model of epilepsy, two splice variants differing
in the region of the voltage sensor S4 of domain III were produced
alternatively when the activity of the channel was left uncontrolled or
when it was inhibited by phenytoin [67].
Fig. 2. NaV1.5 promotes breast cancer cell invasiveness and metastatic progression. Invasive breast cancer cells escape from the primary tumor by degrading and migrating through the
extracellular matrix (ECM), allowing them to reach the blood circulation and eventually to colonize and form secondary tumors (metastases) in distant organs, such as lungs. The prote-
olysis of the ECM by cancer cells is dependent on the formation and activity of protrusive structures, enriched in F-actin, called invadopodia (magniﬁcation). NaV1.5 channels are abnor-
mally expressed in highly invasive breast cancer cells [14,24], and are localized in caveolin-1 (Cav-1)-containing lipid rafts in invadopodia [50]. They are co-localized with Na+-H+
exchanger type 1 (NHE-1) and promote their activity of proton extrusion. This leads to a peri-invadopodial acidiﬁcation favorable to the activity of acidic cysteine cathepsins (Cath), re-
leased by cancer cells, and to the ECM degradation [50,73]. Furthermore, NaV1.5 activity sustains Src kinase activity, the phosphorylation (Y421) of the actin nucleation-promoting factor
cortactin, and the polymerization of actin ﬁlaments [74]. These results suggest that NaV1.5 activity in cancer cells enhances both the formation and ECM degradative activity of
invadopodia. NaV1.5 activity can be inhibited by sodium channels blockers such as tetrodotoxin (TTX), ranolazine and phenytoin thus reducing cancer cell invasiveness in vitro and met-
astatic colonization of organs in vivo [98,99]. The n-3 polyunsaturated fatty acid docosahexaenoic acid (DHA, 22:6n-3) reduces the expression of SCN5A gene through the participation of
the lipid-sensitive transcription factor peroxisome proliferator activated receptor (PPAR)-β, therefore leading to a decreased activity of NHE-1 and a reduced invasion [65,66].
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mouse cardiac ventricular myocytes, where the sodium inﬂux through
NaV1.5 leads to the activation of the kinase CaMKII (resulting from the
reverse-mode sodium-calcium-driven increase in intracellular calcium
concentration that allows CaMKII and NaV1.5 interaction) and the re-
ciprocal increase in NaV1.5 activity (from its phosphorylation by
CaMKII), further increasing the intracellular sodium concentration [68].
Another example showing a reciprocity between VGSC and partner
proteins was given by a study in cerebellar granule neurons. NaV1.6 lo-
calization at the axonal initial segment required its associationwithNaV
β1 subunit. Reciprocally, the role played by β1 required NaV1.6 activity
and sodium ions since the highly speciﬁc inhibitor of VGSC tetrodotoxin
(TTX) or the reduction of extracellular sodium concentration reduced
neurite outgrowth [69]. Neurite outgrowth also required the association
of β1 with ankyrin-G, fyn kinase and contactin [51,69]. How sodium
ions regulate the activity of the complex is however not known.
The VGSC protein could modulate the behavior of cells through
non-electrogenic mechanisms. For example, it has been shown that
zebraﬁsh embryo cardiac cell proliferation is impaired if Scn5Lab
(NaV1.5 ortholog in zebraﬁsh) is not expressed and that this observa-
tion is apparently independent of the channel function since a sodium
current cannot yet be recorded at this stage of the embryo development
[4,6].Sodium-calcium exchangers (NCX) were shown to be the link be-
tween VGSC activity and cell migration. In oligodendrocyte progenitor
cells NG2, GABA(A) receptors induced a depolarization that was able
to activate a voltage-gated sodium channel and a non-inactivating
Na+ current, which in turn allowed the reverse mode functioning of
NCX-1. This led to an increased calcium concentration and NG2 cell mi-
gration [70].
Available studies providing such examples of feedback are scarce,
evenmore in cancer cell models. How the activity of VGSC can increase
themotility or invasiveness of cancer cells, therefore increasing the risk
of metastases development, remains largely unknown, merely because
proteins that transduce the activity of VGSC into a signaling pathway
have been less extensively studied than in neurons or cardiac cells.
As already indicated above, reactivation of silenced genes in cancer
proteins is a frequent phenomenon [30,31]. Since carcinoma cells
abnormally express adult or neonatal VGSC, it would not be surprising
to ﬁnd that they also express neuronal or muscular proteins that are
capable of interaction with VGSC.
A few studies exist that try to elucidate how VGSC increase migra-
tion and invasiveness of cancer cells.
An interesting study performed in breast cancer cell lines MDA-MB-
231 and MCF-7 identiﬁed a positive feedback loop between PKA and
VGSC (neonatal nNaV1.5) inMDA-MB-231 cells, where PKA stimulation
2498 P. Besson et al. / Biochimica et Biophysica Acta 1848 (2015) 2493–2501increased mRNA and plasma membrane protein level of nNaV1.5 and
increased cell migration and invasion. Further proof of the positive
feedback loop was permitted with the use of TTX, which inhibited
nNaV1.5, reducedmigration and invasion, and also reduced the fraction
of phosphorylated, active PKA [71]. This activity-dependent positive
feedback was absent in MCF-7, which do not have VGSC activity.
Processing of the extracellular matrix by proteases is a potentiating
phenomenon for migration and invasion of cancer cells. Endocytic or
exocytic vesicle trafﬁcking was studied in prostate cell lines expressing
(Mat-Lylu) or not (AT-2) functional VGSC. Trafﬁcking was shown to
be twice as high in the highly metastatic Mat-Lylu cells as in the other
less metastatic cell line. TTX treatment or Na+-free medium reduced
vesicle trafﬁcking by half in Mat-Lylu cells, but had no reducing effect
in AT-2 cells which are devoid of VGSC, clearly indicating that VGSC
activity and sodium ions were involved in the enhanced endocytic and
exocytic vesicle trafﬁcking [72]. A very interesting study in a monocytic
cell line, THP-1, and in primary humanmonocyte-derivedmacrophages
showed that VGSC were expressed intracellularly and were functional:
NaV1.6 was associatedwith cytoskeletal ﬁlaments and the endoplasmic
reticulum; NaV1.5 was localized in late endosomes. NaV1.5 was shown
to be functional, resulting in the efﬂux of sodium from the endosomes
and in intraendosomal acidiﬁcation. Inhibition of NaV1.5 by TTX
prevented phagocytosis, sodium efﬂux and endosomal acidiﬁcation
[28]. In a model of breast cancer using MDA-MB-231 cell line, in con-
trast towhatwas found in prostate cell lineMat-Lylu, secretion of acidic
cathepsins was not a NaV1.5-dependent phenomenon. Rather, NaV1.5
enhanced the acidiﬁcation of the extracellular perimembrane environ-
ment, creating a locally favorable milieu for the activity of extracellular
matrix-degrading acidic cathepsins (Fig. 2). Invasion of the extracellular
matrix, perimembrane acidiﬁcation and cathepsins activity were re-
duced in the presence of TTX or when NaV1.5 expression was reduced
by small-interfering RNA. In contrast, invasion was increased when
the sustained sodium current present as a window current at themem-
brane potential of MDA-MB-231 cells was increased by a treatment
with channel opener veratridine [73]. It was then shown in the same
cells that the acidiﬁcation of the perimembrane extracellular environ-
ment was due to a functional link between the activity of the Na+/
H+ exchanger NHE-1 and that of NaV1.5. Decreasing the expression
of NaV1.5 with small interfering RNA or reducing its activity by TTX
treatment reduced the activity of NHE-1. The two proteinswere detect-
ed at the same location in caveolin-richmembrane lipid rafts [50]. NHE-
1, NaV1.5 and caveolin-1 co-immunoprecipitated, indicating a close as-
sociation, and they were found at focal sites of matrix remodeling in
invadopodia of MDA-MB-231 cells. It was also found that NaV1.5 en-
hanced the activity of NHE-1 through an allosteric regulation mecha-
nism (the nature of which was not elucidated), rendering it more
active at less acidic intracellular pH. In parallel of its action on NHE-1,
NaV1.5 activity altered cell morphology, invadopodia formation, and
actin cytoskeleton and promoted the phosphorylation of actin-
nucleation-promoting factor cortactin on Y421 by a member of the Src
family kinase [74]. VGSC are not only involved in the activity of
invadopodia in cancer cells [50,74–76] or podosomes in normal cells
[77] but they participate in their formation [74,77].
To summarize, VGSC activity can increase vesicle trafﬁcking [72],
enhance the activity of acidic cathepsins that digest the extracellular
matrix [73], increase the activity of NHE-1 through an allosteric mecha-
nism which arouses its activity for less acidic intracellular pH [50],
facilitate the dynamics of invadopodia formation and activity, in part
through the stimulation of Src kinase and actin cytoskeleton remodeling
[74]. It is also important to note that, although they are not found at
their generally known plasma membrane location, intracellular VGSC
can be functional in some organelles as was shown in late endosomes
of macrophages, where they participate in phagocytosis [28].
The rare studies investigating the events, downstream of VGSC, that
enhance migration and invasion were performed in a limited array of
breast or prostate cancer cell lines. Extending these studies to othercellular models (other breast and prostate cell lines, as well as other
cancer types) would be helpful to elucidate the role of sodium ions or
the protein itself as a scaffolding element.
5. Sodium appears to be an important factor, but so is
membrane potential
VGSC could exert their effects on the enhancement of migration
and invasion through the increase in Na+ concentration in the cyto-
sol, through the change in membrane potential or through non-
electrogenic mechanisms.
Several studies demonstrated that sodium was an important factor
in the effects generated by VGSC current onmigration and invasiveness:
using a sodium-free extracellular medium [14,78] or, on the contrary,
using channel opener veratridine alone [73,77] and veratridine plus
channel blocker TTX [73] indicated that sodium was involved in VGSC-
dependent migration and invasiveness.
Sodium inﬂux is important as it depolarizes the membrane and
can therefore allow the reverse mode functioning of sodium-calcium
exchangers NCX [68,70], which will increase cytosolic calcium concen-
tration and enhance migration/invasion [79].
In an experiment aiming to show if a regulatory feedback existed
between the electrical activity of a neuron and VGSC density at the
membrane of rat brain neurons, the importance of sodiumwas demon-
strated. When VGSC were active, a reduction of their density could be
observed within 15–30 min. This down-regulation was lost when TTX
was used to inhibit the channel or when Li+ were used to replace
Na+; the down-regulating effect was independent of the protein
since, under condition of inhibition by TTX, the increase in intracellular
sodium (triggered by the membrane ionophore monensin, capable of
transporting Na+) restored the down-regulation of VGSC [80].
Sensors of intracellular sodium concentration exist such as the
sodium-dependent potassium channels Slack and Slick (for a review
see [81]). If one postulates that cytosolic calcium concentration is in-
creased by the reverse functioning of NCX, which occurs when the
membrane potential is more depolarized than −40 mV, Slack and
Slick would be irrelevant with the issue of regulation of migration and
invasion. However, intracellular calcium concentration can increase
through TRP channels or Orai channels, provided that they are activated
by theproper condition [82]. Since the efﬂux of potassium through Slack
and Slick will hyperpolarize the membrane, it will increase the driving
force that will allow calcium to enter the cell through TRP or Orai.
It has been reported that Na+ could activate NMDA receptors, and
that Src family kinases were involved in this effect but the authors
were still looking for the sensor [83].
Although G protein-coupled receptors (GPCR) do not directly inter-
act with VGSC, they could share common downstream signaling path-
ways and cooperate or compete for the ﬁnal effect they are expected
to generate. A recent study showed that GPCR possess a binding site
for one sodium ion and that this ion is important for the stabilization
and activity of the receptor. This could be considered a sensor of intra-
cellular sodium concentration [84].
Therefore, it appears that Na+ is important in the downstream
effects of VGSC but how it is sensed and whether all the proteins cited
above are the direct Na+ sensors remains unexplained. Furthermore,
similar regulatory effects of Na+ could occur in cancer cells which do
not express VGSC. For example, cells expressing other Na+-permeable
channels types such as purinergic receptor P2X7 [85] could have a
similar Na+-dependent regulatory mechanism of invasive properties.
Membrane potential is modiﬁed by the inﬂux of sodium through
VGSC, but also by the other permeabilities that are active in the studied
cells [79,86]. In cancer cells,membranepotential is generally depolarized
as compared to excitable cells [86] and at this potential, VGSC present
awindow current that results in a permanent inﬂux of sodium.Whether
membrane potential is important or sodium is important, they are both
intertwined and displacing the membrane potential to a more positive
2499P. Besson et al. / Biochimica et Biophysica Acta 1848 (2015) 2493–2501or more negative potential could place the VGSC at a potential where
they become fully inactive and no longer let sodium enter the cell.
Membrane potential is indeed very important for the conformation
of plasmamembrane proteins but also for the conformation of cytosolic
proteins [79] as was shown for example for the phosphoinositide phos-
phatase Ci-VSP in Xenopus oocytes, or actin cytoskeleton in endothelial
cells (for a review see [79]). Themembrane potential of cells located at a
distant site from the tumorigenic site is inﬂuential aswell, aswas shown
in a recent study by Chernet and Levin [87]: hyperpolarizing cells in
Xenopus embryos at a distant site from the tumorigenic oncogene-
expressing cells resulted in a reduction of tumor-like structures forma-
tion. Hyperpolarization itself was sufﬁcient, whether it was achieved
through the activity of K+ or Cl− channels. The long distance signaling
between the hyperpolarized cells and oncogene-expressing cells was
apparently not an electrical signaling but was in part mediated through
the production of butyrate by the host microbiota, the inﬂux of butyrate
into the oncogene-expressing cells and inhibition of histone deacetylase
by butyrate, resulting in tumor cell proliferation arrest.
6. Non electrogenic role of VGSC
VGSC being part of the multiprotein scaffold in lipid rafts, in caveo-
lae, they are likely to inﬂuence their partners through direct interaction.
The example given above in Section 4, to show that VGSC can exert their
effect through a non-electrogenic mechanism, was not a study on the
migration or invasion of cancer cells but on the proliferation of zebraﬁsh
embryo cardiomyocytes [4,6]. To the best of our knowledge, no such
study exists for cancer cells. This should be done, and could be done
to thebest using loss-of-function (non-pore)mutants of VGSC, although
all of which, unfortunately for the sake of research, are not fully non-
permeant [88–90].
7. Conclusion
The discovery of VGSC in cancer cells is quite recentwhen compared
to excitable cells. However, understanding their functioning in cancer
cells progressed at a fast rate thanks to all the knowledge that was
accumulated studying neurons and muscle cells. Knowing how the ex-
pression and functioning of VGSC are regulated in cancer cells is certain-
ly very valuable because it givesmultiple different approaches as how to
potentially decrease their activity and therefore reduce the formation of
metastases. However, since VGSC are also expressed in normal macro-
phages and lymphocytes, inhibiting sodium channels altogether in
immune cells and cancer cells might reduce the beneﬁt that could be
expected in the inhibition of metastases formation. For this reason,
identifying the downstreamproteins that are regulated by VGSC activity
is also very important and would help ﬁnd cancer cell speciﬁc treat-
ments, by enlarging the array of therapeutic targets. The study by
House et al. [20], presents a novel and very efﬁcient bioinformatics
approach combining the analysis of transcriptomics and invasion exper-
iments, which allowed identifying a large array of genes/proteins in-
volved in colon cancer cell behavior under the functional expression
of NaV1.5. This method, called “factor graph nested effects model”
[91] seeks interactions (transcriptional or functional) among silenced
genes/proteins and downstream effect genes/proteins. This is a very
powerful approach that could valuably be reproduced in many cancer
types to predict the downstream effectors of VGSC in speciﬁc tissues.
The abnormal expression of VGSC in cancer cells, particularly in the
form of neonatal isoforms, suggests that some of the other partners of
VGSC in the multiprotein platforms are likely to be neonatal isoforms
as well. This should be investigated because what was discovered in
normal excitable cells might not be identical in cancer cells. Finding
the effectors that are sensitive to the intracellular sodium concentration
will also be important and could help broaden the therapeutic arsenal
against metastases. Moreover, if sodium concentration is the key, the
discovery of the sodium sensors would enlarge this particular ﬁghtagainst metastases to tumors that do not express VGSC but express
non-voltage-gated sodium transporters or sodium channels. Last, the
study of the association of partner proteins in lipid rafts could help
ﬁnd pharmacological or nutritional lipids that would disrupt the associ-
ation and reduce the pro-metastatic property of VGSC.
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